Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

This study has been completed.
Information provided by (Responsible Party):
LEO Pharma Identifier:
First received: January 30, 2009
Last updated: March 2, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)